Literature DB >> 16078270

Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.

Eric Montgomery1, Catherine Pennington, Carlos M Isales, Mark W Hamrick.   

Abstract

We have investigated muscle-bone interactions using two mouse mutants that are known to differ from normal mice in skeletal muscle growth and development: mice lacking myostatin (GDF8) and mice lacking dystrophin (mdx). Myostatin-deficient mice show increased muscle size and strength compared to normal mice, whereas the mdx mouse is a well-established animal model for Duchenne muscular dystrophy. The mdx mice have significantly larger hindlimb muscles than controls, and histological sections of the quadriceps muscles show dystrophic changes with extensive fibrosis. Femoral bone mineral density (BMD) and fracture strength (Fu) are significantly greater in mdx mice than controls, and these variables are more strongly correlated with quadriceps muscle mass than with body mass. In contrast, mdx mice do not shower high bone mineral density in the spine relative to controls, whereas myostatin-deficient mice have significantly increased BMD in the lumbar spine compared to normal mice. Both mdx mice and myostatin-deficient mice have expanded femoral trochanters for attachment of large hindlimb muscles, and both mutant strains show increased cross-sectional area moments of inertia mediolaterally (Iyy) but not anteroposteriorly (Ixx) compared to normal mice. These data suggest that lean (muscle) mass is a significant determinant of bone mineral density and strength in the limb skeleton, even when accompanied by a dystrophic phenotype. Likewise, increased muscle mass produces a marked increase in the external dimensions of muscle attachment sites, even when increased muscle size is accompanied by extensive fibrosis and muscle weakness. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078270     DOI: 10.1002/ar.a.20224

Source DB:  PubMed          Journal:  Anat Rec A Discov Mol Cell Evol Biol        ISSN: 1552-4884


  18 in total

1.  Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.

Authors:  M L Bianchi; L Morandi; E Andreucci; S Vai; J Frasunkiewicz; R Cottafava
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  The relationship between bone mechanical properties and ground reaction forces in normal and hypermuscular mice.

Authors:  Daniel Schmitt; Ann C Zumwalt; Mark W Hamrick
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2010-07-01

3.  Prednisolone treatment and restricted physical activity further compromise bone of mdx mice.

Authors:  S A Novotny; G L Warren; A S Lin; R E Guldberg; K A Baltgalvis; D A Lowe
Journal:  J Musculoskelet Neuronal Interact       Date:  2012-03       Impact factor: 2.041

Review 4.  Muscle-bone interactions: basic and clinical aspects.

Authors:  Luisella Cianferotti; Maria Luisa Brandi
Journal:  Endocrine       Date:  2013-08-29       Impact factor: 3.633

5.  Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.

Authors:  Brian C Goh; Vandana Singhal; Angelica J Herrera; Ryan E Tomlinson; Soohyun Kim; Marie-Claude Faugere; Emily L Germain-Lee; Thomas L Clemens; Se-Jin Lee; Douglas J DiGirolamo
Journal:  J Biol Chem       Date:  2017-06-28       Impact factor: 5.157

6.  Bone is functionally impaired in dystrophic mice but less so than skeletal muscle.

Authors:  Susan A Novotny; Gordon L Warren; Angela S Lin; Robert E Guldberg; Kristen A Baltgalvis; Dawn A Lowe
Journal:  Neuromuscul Disord       Date:  2011-01-21       Impact factor: 4.296

7.  Role of muscle-derived growth factors in bone formation.

Authors:  M W Hamrick; P L McNeil; S L Patterson
Journal:  J Musculoskelet Neuronal Interact       Date:  2010-03       Impact factor: 2.041

8.  Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

Authors:  Christian Isaac; Adam Wright; Arvydas Usas; Hongshuai Li; Ying Tang; Xiaodong Mu; Nicholas Greco; Qing Dong; Nam Vo; James Kang; Bing Wang; Johnny Huard
Journal:  J Orthop Res       Date:  2012-10-23       Impact factor: 3.494

9.  The chondrogenic response to exercise in the proximal femur of normal and mdx mice.

Authors:  David J Nye; Jeffrey M Costas; Jessica B Henley; Jin-Kwang Kim; Jeffrey H Plochocki
Journal:  BMC Musculoskelet Disord       Date:  2010-09-03       Impact factor: 2.362

10.  Evaluation of myostatin as a possible regulator and marker of skeletal muscle-cortical bone interaction in adults.

Authors:  Nagato Kuriyama; Etsuko Ozaki; Teruhide Koyama; Daisuke Matsui; Isao Watanabe; Satomi Tomida; Reo Nagamitsu; Kanae Hashiguchi; Masaaki Inaba; Shinsuke Yamada; Motoyuki Horii; Shigeto Mizuno; Yutaro Yoneda; Masao Kurokawa; Daiki Kobayashi; Shinpei Fukuda; Koichi Iwasa; Yoshiyuki Watanabe; Ritei Uehara
Journal:  J Bone Miner Metab       Date:  2020-10-12       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.